Oligonucleotides specific for hepatitis B virus
US6984729B1 · kind B1 · utility
5Cited by
4References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 1997 |
| Grant date | Jan 10, 2006 |
| Priority date | — |
| Expiry date | Jul 28, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention discloses synthetic oligonucleotides complementary to contiguous and noncontiguous regions of the HBV RNA. Also disclosed are methods and kits for inhibiting the replication and expression of HBV, and for treating HBV infections and associated conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.